Monday, 01 June 2015 03:49

Drug Safety Update: Risks of severe bradycardia and heart block when taken with amiodarone

Written by
Rate this item
(1 Vote)

On the 20th May 2015 the Medicines and Healthcare products Regulatory Agency in the UK issued a Drug Safety Update titled:

Sofosbuvir with daclatasvir; sofosbuvir and ledipasvir: risks of severe bradycardia and heart block when taken with amiodarone.

You will find a link to it at:

https://www.gov.uk/drug-safety-update/sofosbuvir-with-daclatasvir-sofosbuvir-and-ledipasvir-risks-of-severe-bradycardia-and-heart-block-when-taken-with-amiodarone

Read 4294967295 times Last modified on Sunday, 30 August 2015 03:59